Evonik gets go-ahead, for now

20 May 2012

German ECM bankers were last week reluctant to write off the chances of speciality chemicals firm Evonik in the IPO market even as other deals fell away.

And on Monday, the board of RAG-Stiftung, the 75% owner of Evonik, allowed preparations to continue thought they warned that the market conditions meant the timing might need to be reconsidered.

Bankers expect a decision to be taken in the next week or so.


Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial